Apyx Medical Corporation (APYX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 3.03 |
| Open | 3.06 |
| Day High | 3.12 |
| Day Low | 3.05 |
| 52-Week High | 5.08 |
| 52-Week Low | 1.7 |
| Volume | 52,579 |
| Average Volume | 121,682 |
| Market Cap | 131.38M |
| PE | -15.6 |
| EPS | -0.2 |
| Moving Average 50 Days | 4 |
| Moving Average 200 Days | 3.85 |
| Change | 0.09 |
Apyx Medical Corporation to Release Fourth Quarter of Fiscal Year 2025 Financial Results on March 10, 2026
GlobeNewswire Inc.
Feb 25, 2026 2:00 PM GMT
CLEARWATER, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announ
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference
GlobeNewswire Inc.
Feb 18, 2026 1:00 PM GMT
CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announ
Apyx Medical Corporation to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
GlobeNewswire Inc.
Jan 29, 2026 1:00 PM GMT
CLEARWATER, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announ